Back
Speaker illustration

Professor Ana Moya

Cardiovascular Research Center Aalst, Aalst (Belgium)

Member of:

European Association of Cardiovascular Imaging

Biomedical researcher and doctor in Cardiovascular Pathologies and Therapeutics. Interested in Cardio-Oncology, Cardiovascular Physiology in dyspnea (CPET-echo) and Advanced Echocardiography. Research domains: aortic valve stenosis and TAVR, cardio-oncology, heart failure, hypertrophic cardiomyopathy and congenital heart diseases.

Presentations Articles

Addressing cardiotoxicity: insights from a multidisciplinary care pathway for cancer patients

Event: ESC Cardio-Oncology 2025

Topic: Organisation of a Cardio-Oncology Service

Session: Transforming cardio-oncology care: models, innovations, and collaborative practice

Access
Like
Thumbnail

Reclassification of patients with stage 2 or higher severe aortic valve stenosis based on left atrial reservoir strain

Event: EuroEcho-Imaging 2024

Topic: Valvular Heart Disease

Session: More on aortic stenosis

Access
Like
Thumbnail

Myocardial work assessment for immediate changes in left ventricular function and survival analysis after transcatheter aortic valve replacement

Event: Heart Failure 2024

Topic: Intervention

Session: Improving prognosis in aortic valve disease

Access
Like
Thumbnail

Combined TEER and TAVR in patient with severe MR and AS

Event: Heart Failure 2023

Topic: Valvular Heart Disease

Session: Valvular heart disease 2

Access
Like
Thumbnail

Myocardial work for LV function assessment in severe AS patients undergoing TAVR

Event: Heart Failure 2023

Topic: Imaging

Session: Chronic heart failure - imaging 1

Access
Like
Thumbnail

Prognostic value of baseline wasted myocardial work and serum troponines in severe AS patients referred for TAVR

Event: Heart Failure 2023

Topic: Epidemiology, Prognosis, Outcome

Session: Valvular heart disease

Access
Like
Thumbnail

Myocardial work analysis for early detection of type 1 CTRCD and patient risk stratification

Event: ESC Congress 2022

Topic: Cardiotoxicity of Drugs and Other Therapies

Session: Chroninc heart failure - Comorbidities

Access
Like
Thumbnail

Global longitudinal strain and NT-proBNP as predictors for LV function recovery after TAVR

Event: ESC Congress 2022

Topic: Aortic Valve Stenosis

Session: Predictors of outcomes in transcatheter aortic valve replacement

Access
Like
Thumbnail

Additive value of soluble ST2 to NT-proBNP for more accurate patient risk stratification and long-term survival prediction after TAVI

Event: Heart Failure 2022

Topic: Epidemiology, Prognosis, Outcome

Session: Heart Failure ePosters - focus on Valvular Heart Disease & Interventional Cardiology

Access
Like
Thumbnail

Role of myocardial work index in early detection of cardiotoxicity in breast cancer patient

Event: ESC Congress 2021 - The Digital Experience

Topic: Imaging

Session: Acute heart failure e-posters

Access
Like
Thumbnail

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources